title: Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults.
abstract: BACKGROUND
  The purpose of this study was to determine the anabolic effects of recombinant human insulin-like growth factor-I (rhIGF-1) complexed with its principal binding protein IGF-1 binding protein-3 (IGFBP-3) in severely burned adults.
  
  
  METHODS
  Ten burned adults were studied consecutively after receiving saline (pretreatment), then rhIGF-1/IGFBP-3 (treatment) for 5 days. Doses were 1, 2, and 4 mg/kg per day. Glucose, electrolytes, hormones, and leg muscle protein metabolism were determined. Nine other studies were performed on similarly injured adults at comparable times to the treatment studies to control for time effects.
  
  
  RESULTS
  Serum IGF-1 and IGFBP-3 levels increased with all doses, but no incremental increases were found. Leg protein balance improved with rhIGF-1/IGFBP-3, which was associated with an increase in muscle protein fractional synthetic rate. These effects were independent of time. All patients were euglycemic without electrolyte imbalances.
  
  
  CONCLUSIONS
  Net protein synthesis in the isolated leg of severely burned adults improved with rhIGF-1/IGFBP-3 without development of glucose abnormalities.
authors.affiliation: Shriners Hospitals for Children, Galveston, Texas 77550, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Debroy
authors.forename: S E
authors.initials: SE
authors.lastname: Wolf
authors.forename: X J
authors.initials: XJ
authors.lastname: Zhang
authors.forename: D L
authors.initials: DL
authors.lastname: Chinkes
authors.forename: A A
authors.initials: AA
authors.lastname: Ferrando
authors.forename: R R
authors.initials: RR
authors.lastname: Wolfe
authors.forename: D N
authors.initials: DN
authors.lastname: Herndon
mesh_terms: D000328:Adult; D002056:Burns / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000008:administration & dosage* / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins / Q000378:metabolism; D011994:Recombinant Proteins / Q000008:administration & dosage
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D009124:Muscle Proteins; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I